相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Somatic activating ARAF mutations in Langerhans cell histiocytosis
David S. Nelson et al.
BLOOD (2014)
Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma
Marcin Imielinski et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Marie-Luise Berres et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Pathogenesis of Langerhans Cell Histiocytosis
Gayane Badalian-Very et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
Julien Haroche et al.
BLOOD (2013)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia
Mignon L. Loh
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Recurrent BRAF mutations in Langerhans cell histiocytosis
Gayane Badalian-Very et al.
BLOOD (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
分享论文
